Axiora Medical
Designed to conform to European clinical parameters, ensuring early weight-bearing stability and precise anatomical alignment.
The Netherlands possesses one of the most advanced healthcare systems globally, managed through a network of elite Academic Medical Centers (UMCs), top-tier regional hospitals (STZ), and Level-1 Trauma Centers. Within this medical infrastructure, the treatment of long bone fractures—especially of the femur, tibia, and humerus—demands high-performance implantable devices. There is an increasing clinical transition from traditional plating methods to advanced, load-sharing Intramedullary (IM) Nailing systems to encourage early mobilization.
However, Dutch medical device distributors and purchasing consortia face unprecedented hurdles due to the strict enforcement of the **EU Medical Device Regulation (EU-MDR 2017/745)**. With several local and European manufacturers rationalizing their product lines due to the rising costs of regulatory certification, the supply chain for osteosynthesis devices has tightened. This has created a critical need for reliable OEM/ODM partners capable of producing biocompatible implants that meet strict biomechanical and safety standards.
| Dutch Market Import & Regulatory Baseline | |
|---|---|
| Regulatory Standard | EU-MDR 2017/745 Compliance & CE marking required for clinical use. |
| Material Requirements | ASTM F136 Titanium Alloy / ISO 5832-3 Implantation Grade. |
| Local Distribution Hub | Port of Rotterdam & Schiphol Logistics Corridor. |
| Key Clinical Indicators | Rotational stability, minimum instrumentation footprints, biocompatibility. |
Collaborating with **Axiora Medical Technology** offers Dutch distributors and global brand owners a clear competitive edge. By bridging advanced Chinese manufacturing efficiency with stringent Western standards, we supply high-performance orthopedic implants at sustainable prices.
Operating a state-of-the-art 18,600 m² factory equipped with modern Swiss longitudinal cutting lathes and multi-axis CNC machines, Axiora ensures sub-micron level precision for every locking screw thread and cannulated nail shaft. Our 8-year export track record to highly regulated European and North American markets demonstrates our capacity to support your brand with reliable volume, customized labeling, and complete technical documentation.
Ensuring micro-invasive applications, minimized bone displacement, and rapid patient recovery.
Pioneering clinical outcomes through advanced metallurgic engineering and biomechanical designs.
Our titanium implants undergo specialized Type II anodization, creating a hard oxide surface layer that reduces friction coefficient, limits cold welding risks with screws, and significantly elevates fatigue threshold limits.
Designed with static and elongated dynamic interlocking options, our nails allow controlled fracture axial compression during early postoperative walking, helping to minimize non-union risks.
For osteoporotic cases common in Western Europe's aging demographics, our PFNA helical blades compress trabecular bone structure instead of cutting it, providing superior resistance to cut-out.
Uncompromising control from trace-validated titanium raw materials to final ISO Class 5 sterile-barrier aseptic packaging.























We are a professional manufacturer specializing in the research, development, production, and global supply of high-quality orthopedic implants and surgical instruments. Our product portfolio covers trauma fixation systems, spinal implants, joint reconstruction solutions, sports medicine products, and related orthopedic surgical instruments.
Established with a commitment to innovation and precision manufacturing, Axiora integrates advanced CNC machining, automated production lines, and strict quality management systems to deliver reliable products that meet international standards. Our experienced engineering team continuously develops innovative solutions to support surgeons and healthcare providers worldwide.
With strong OEM and ODM capabilities, we provide customized manufacturing services according to customers' drawings, samples, and technical requirements. From product design and prototyping to mass production and packaging, our integrated manufacturing process ensures consistent quality, competitive pricing, and on-time delivery.
| Item | Details |
|---|---|
| Company Name | Axiora Medical Technology (China) Co., Ltd. |
| Brand | Axiora |
| Established | 2017 |
| Factory Area | 18,600 m² |
| Export Experience | 8 Years (Serving Europe, North America, Southeast Asia) |
| R&D Capability | Independent Design, Reverse Engineering, Custom OEM/ODM |
| Inspection Methods | CMM, Tensile testing, Hardness and Surface Roughness Metrology |
Engineered for high fatigue resistance, optimal load transmission, and anatomical precision.
Minimizing lead times and ensuring complete regulatory support to help streamline importing through the Port of Rotterdam.
For European buyers, logistics costs and custom clearings play a major role in procurement efficiency. Axiora leverages its strategic position near mainland China logistics corridors to offer competitive shipping terms. We coordinate directly with freight forwarders to manage smooth shipping to major European hubs like the Port of Rotterdam and Schiphol Cargo Airport.
Additionally, we provide a structured warehousing model that supports "Safety Stock Buffer Schemes" for our long-term contract partners. By maintaining pre-machined titanium bodies, we can quickly respond to sudden spikes in trauma implant demands, helping you avoid standard manufacturing queues.
Key technical and logistics questions addressed by our engineering and regulatory affairs teams.